Department of Pharmacology, SKNMC, Narhe, Ambegaon, Pune, India.
CNS Neurosci Ther. 2010 Oct;16(5):e180-4. doi: 10.1111/j.1755-5949.2010.00165.x. Epub 2010 Jun 16.
To evaluate hypnosedative action of Zopiclone by using animal models for hypnosis and sedation (anxiolysis); and to further evaluate whether this hypnosedation impairs memory-learning in albino mice like conventional hypnosedatives.
For evaluation of hypnosedation, following experiments were performed in albino mice: (1) righting reflex test, (2) pentobarbitone sleeping time potentiation, (3) open field apparatus behavior, and (4) elevated plus maze performance. For evaluation of effects on impairment of memory-learning, elevated plus maze retention test was performed in albino mice.
Zopiclone (7.5 mg/kg p.o.) did not inhibit the righting reflex. Significant (P < 0.001) potentiation of pentobarbitone sleeping time and increase in exploration in open field apparatus was observed. Elevated plus maze performance also showed significant (P < 0.01) increase in number of entries to open arm at the same time significant (P < 0.02) increase in time spent in open arm was observed. Elevated plus maze retention test showed significant (P < 0.01) increase in transfer latency on second day of experiment.
Zopiclone (7.5 mg/kg p.o.) has selective hypnosedative activity but not CNS-depressant activity similar to BZDs. Hypnosedative action of Zopiclone does not impair memory-learning in albino mice like conventional hypnosedatives.
通过催眠和镇静(抗焦虑)的动物模型评估佐匹克隆的催眠作用;并进一步评估这种催眠作用是否像传统催眠药一样损害白化病小鼠的记忆学习能力。
在白化病小鼠中进行了以下实验来评估催眠作用:(1)翻正反射试验,(2)戊巴比妥睡眠时间增强,(3)旷场行为,(4)高架十字迷宫表现。为了评估对记忆学习损伤的影响,在白化病小鼠中进行了高架十字迷宫保留测试。
佐匹克隆(7.5mg/kg 口服)不抑制翻正反射。观察到戊巴比妥睡眠时间显著增强(P<0.001)和旷场仪器中探索增加。高架十字迷宫表现也显示出进入开放臂的次数显著增加(P<0.01),同时在开放臂中花费的时间显著增加(P<0.02)。高架十字迷宫保留测试显示第二天的转移潜伏期显著增加(P<0.01)。
佐匹克隆(7.5mg/kg 口服)具有选择性催眠作用,但与 BZDs 不同,没有中枢抑制剂活性。佐匹克隆的催眠作用不会像传统催眠药一样损害白化病小鼠的记忆学习能力。